Skip to main content

Table 3 Cardiac prescriptions, physicians and emergency room visits post-discharge after acute myocardial infarction

From: Impact of on-site cardiac catheterization on resource utilization and fatal and non-fatal outcomes after acute myocardial infarction

 

Hospitals with Catheterization Facilities (n = 4,116)

Hospitals without Catheterization Facilities (n = 11,190)

Medication class* (%)

   Aspirin

65.4

64.2

   Beta-blockers

57.7

52.6

   ACE inhibitors

45.2

44.0

   Nitrates (any form)

72.7

73.0

   Calcium channel blockers

27.6

28.1

   Lipid-lowering agents

24.9

20.8

Anti-ischemic combination therapy at 1 year (%)

   Monotherapy

38.8

41.6

   Double therapy

27.3

27.9

   Triple therapy

7.8

7.2

Refills for sublingual nitrates at 1 year (%)

31.4

28.7

Emergency room visits at 1 year (%)

   0 visits

43.3

43.3

   1–3 visits

41.4

41.3

   ≤4 visits

15.4

15.4

Physician visits at 1 year (%)

  

   0–3 visits

22.3

18.9

   4–8 visits

38.5

39.7

   ≤9 visits

39.2

41.4

  1. ACE denotes angiotensin-converting enzyme.
  2. * For patients ≤65 years of age only; Anti-ischemic combination therapy was defined as prescription for one (monotherapy), two (double therapy) or three (triple therapy) agents among beta-blockers, nitrates, and calcium channel blockers at six months post-discharge (for patients ≤65 years of age only, n = 15,306).